In COVID-19 cases, COVID-19-related POTS may also occur due to abnormalities in the immune response and autoimmune system, which can be managed with pyridostigmine, an acetylcholinesterase inhibitor that can be reversed. This evidence concerns the gene ACHE and COVID-19.